Search tips
Search criteria 


Logo of bmjThe BMJ
BMJ. 1994 October 1; 309(6958): 833–837.
PMCID: PMC2541105

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.


OBJECTIVE--To compare the ability of angiotensin converting enzyme inhibitors and beta blockers to slow the development of end stage renal failure in non-diabetic patients with chronic renal failure. DESIGN--Open randomised multicentre trial with three year follow up. SETTING--Outpatient departments of six French hospitals. PATIENTS--100 hypertensive patients with chronic renal failure (initial serum creatinine 200-400 mumol/l. 52 randomised to enalapril and 48 to beta blockers (conventional treatment). INTERVENTIONS--Enalapril or beta blocker was combined with frusemide and, if necessary, a calcium blocker or centrally acting drug in patients whose diastolic pressure remained above 90 mm Hg. RESULTS--17 patients receiving conventional treatment and 10 receiving enalapril developed end stage renal failure. The cumulative renal survival rate was significantly better in the enalapril group than in the conventional group (P < 0.05). The slope of the reciprocal serum creatinine concentration was steeper in the conventionally treated patients (-6.89 x 10(-5)l/mumol/month) than in the enalapril group (-4.17 x 10(-5)l/mumol/month; P < 0.05). No difference in blood pressure was found between groups. CONCLUSION--In hypertensive patients with chronic renal failure enalapril slows progression towards end stage renal failure compared with beta blockers. This effect was probably not mediated through controlling blood pressure.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981 Jul;241(1):F85–F93. [PubMed]
  • Yoshida Y, Fogo A, Ichikawa I. Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int. 1989 Feb;35(2):654–660. [PubMed]
  • Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986 Jun;77(6):1993–2000. [PMC free article] [PubMed]
  • Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int. 1987 Mar;31(3):752–759. [PubMed]
  • Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int. 1989 Oct;36(4):626–635. [PubMed]
  • Parving HH, Hommel E, Smidt UM. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. [PMC free article] [PubMed]
  • Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992 Feb 8;304(6823):339–343. [PMC free article] [PubMed]
  • Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985 Jan;27(1):58–65. [PubMed]
  • Hannedouche T, Laude D, Déchaux M, Grünfeld JP, Elghozi JL. Plasma 5-hydroxyindoleacetic acid as an endogenous index of renal plasma flow. Kidney Int. 1989 Jan;35(1):95–98. [PubMed]
  • Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int. 1989 Feb;35(2):670–674. [PubMed]
  • Alvestrand A, Gutierrez A, Bucht H, Bergström J. Reduction of blood pressure retards the progression of chronic renal failure in man. Nephrol Dial Transplant. 1988;3(5):624–631. [PubMed]
  • Brazy PC, Fitzwilliam JF. Progressive renal disease: role of race and antihypertensive medications. Kidney Int. 1990 Apr;37(4):1113–1119. [PubMed]
  • Hannedouche T, Albouze G, Chauveau P, Lacour B, Jungers P. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis. 1993 May;21(5 Suppl 2):131–137. [PubMed]
  • Mann JF, Reisch C, Ritz E. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron. 1990;55 (Suppl 1):38–42. [PubMed]
  • Ruilope LM, Miranda B, Morales JM, Rodicio JL, Romero JC, Raij L. Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis. 1989 Feb;13(2):120–126. [PubMed]
  • Kamper AL, Strandgaard S, Leyssac PP. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens. 1992 Jul;5(7):423–430. [PubMed]
  • Cameron JS. Proteinuria and progression in human glomerular diseases. Am J Nephrol. 1990;10 (Suppl 1):81–87. [PubMed]
  • Rosenberg ME, Chmielewski D, Hostetter TH. Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest. 1990 Apr;85(4):1144–1149. [PMC free article] [PubMed]
  • Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int. 1987 Jul;32(1):78–83. [PubMed]
  • Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982 Dec 11;2(8311):1309–1311. [PubMed]
  • Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989 Aug;36(2):272–279. [PubMed]
  • Norman JT. The role of angiotensin II in renal growth. Ren Physiol Biochem. 1991 Jul-Oct;14(4-5):175–185. [PubMed]
  • Fenoy FJ, Scicli G, Carretero O, Roman RJ. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension. 1991 Jun;17(6 Pt 2):1038–1044. [PubMed]
  • Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465–490. [PubMed]
  • DAVIES DF, SHOCK NW. The variability of measurement of insulin and diodrast tests of kidney function. J Clin Invest. 1950 May;29(5):491–495. [PMC free article] [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group